Tolcapone at 20 μM inhibited 50% of U87 cell growth, and IL-1RA at 1 μg/mL resulted in a 51% decrease in the IL-1β-induced cancer cell growth in human glioblastoma cancer. The gene discussed is IL1B; the disease is cancer.